Multicore alginate microspheres (MCPs) have been demonstrated
as
promising carriers for bioactive substances. Herein, the influence
of the size of the inner core on the bioaccessibility of astaxanthin
(AST) was investigated using both in vitro and in vivo methods. MCPs
with different inner core sizes were fabricated in which the oil-in-water
emulsion with different oil droplet sizes was embedded in alginate
microspheres (AST@MCPs) via the electrospray technology. The AST@MCPs
appeared as a uniform sphere with an average size of 300 μm.
The AST encapsulation efficiency in the AST@MCPs was determined to
be more than 68%, which was independent of the inner core size. The
bioaccessibility of AST increased from 38.3 to 83.2% as the size of
the inner core decreased. Furthermore, the anti-inflammatory activity
of AST@MCPs after in vitro simulated digestion was evaluated by LPS-induced
RAW264.7 cells. The results suggested that AST@MCPs with a smaller
inner core size exhibited a stronger anti-inflammatory activity, which
further proved the results obtained from in vitro simulated digestion.
As expected, the oral administration of AST@MCPs significantly mitigated
colitis symptoms in DSS-induced ulcerative colitis mice. Compared
with AST@MCPs with larger inner cores, AST@MCPs with smaller inner
cores reflect stronger anti-inflammatory activity in vivo. These results
suggested that the bioaccessibility of AST in MCPs increased significantly
with the decrease in the inner core size, which may be attributed
to the rapid formation of micelles in the intestine. This work provides
a simple and efficient strategy to prepare microspheres for the enhanced
delivery of AST, which has important implications for the design of
health-promoting foods